Stem cells therapy for diabetes: from past to future

Area of Science:

• Regenerative Medicine
• Endocrinology
• Biotechnology

Background:

• Diabetes mellitus is a chronic metabolic disorder marked by hyperglycemia due to insulin deficiency or resistance.
• Current treatments like insulin therapy and transplantation have limitations, including inability to fully replicate endogenous insulin function and donor scarcity.
• Stem cell therapy, combined with gene editing and cell encapsulation, presents a novel therapeutic avenue for diabetes.

Purpose of the Study:

• To review the progress in deriving insulin-producing cells from various stem cell sources.
• To discuss the role of gene editing in enhancing stem cell therapy for diabetes.
• To summarize current cell encapsulation technologies and future prospects for stem cell therapy in diabetes management.

Main Methods:

• Review of current literature on stem cell derivation, gene editing applications, and cell encapsulation techniques for diabetes.
• Analysis of the potential and challenges of different stem cell types for generating insulin-producing cells.
• Evaluation of advanced cell encapsulation strategies for protecting and delivering therapeutic cells.

Main Results:

• Various stem cell types show potential for differentiation into insulin-producing cells.
• Gene editing technologies offer tools to improve stem cell function and safety for diabetes treatment.
• Advanced encapsulation methods are crucial for successful in vivo application of cell therapies.

Conclusions:

• Stem cell-derived insulin-producing cells, enhanced by gene editing and protected by encapsulation, hold significant promise for diabetes treatment.
• Further research is needed to address challenges before widespread clinical application of stem cell therapy for diabetes.
• This review highlights the convergence of stem cell biology, gene editing, and biomaterials in advancing diabetes therapeutics.